Evidence map›Paper›PMID 34255161›Full record

ArticleEuropean radiology2022

Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance.

Nikita Sushentsev, Leonardo Rundo, Oleg Blyuss, Tatiana Nazarenko, Aleksandr Suvorov, Vincent J Gnanapragasam, Evis Sala, Tristan Barrett

Abstract read
In one paragraph

Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Delta radiomics: a systematic review.La Radiologia medica · 2021
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. CT delta-radiomics predicts the risks of blood transfusion and massive bleeding during spinal tumor surgery.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nikita Sushentsev *Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. ns784@medschl.cam.ac.uk.ORCID http://orcid.org/0000-0003-4500-9714
Leonardo Rundo *Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Oleg BlyussSchool of Physics, Engineering & Computer Science, University of Hertfordshire, Hatfield, UK.
Tatiana NazarenkoDepartment of Mathematics and Institute for Women's Health, University College London, London, UK.
Aleksandr SuvorovWorld-Class Research Center "Digital Biodesign and Personalised Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia.
Vincent J GnanapragasamDivision of Urology, Department of Surgery, University of Cambridge, Cambridge, UK.
Evis SalaDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Tristan BarrettDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.

Funding

Cancer Research UK C197/A16465Medical Research Council MR/R02524X/1
6 · The paper itself

Abstract

objectivesTo compare the performance of the PRECISE scoring system against several MRI-derived delta-radiomics models for predicting histopathological prostate cancer (PCa) progression in patients on active surveillance (AS).

methodsThe study included AS patients with biopsy-proven PCa with a minimum follow-up of 2 years and at least one repeat targeted biopsy. Histopathological progression was defined as grade group progression from diagnostic biopsy. The control group included patients with both radiologically and histopathologically stable disease. PRECISE scores were applied prospectively by four uro-radiologists with 5-16 years' experience. T2WI- and ADC-derived delta-radiomics features were computed using baseline and latest available MRI scans, with the predictive modelling performed using the parenclitic networks (PN), least absolute shrinkage and selection operator (LASSO) logistic regression, and random forests (RF) algorithms. Standard measures of discrimination and areas under the ROC curve (AUCs) were calculated, with AUCs compared using DeLong's test.

resultsThe study included 64 patients (27 progressors and 37 non-progressors) with a median follow-up of 46 months. PRECISE scores had the highest specificity (94.7%) and positive predictive value (90.9%), whilst RF had the highest sensitivity (92.6%) and negative predictive value (92.6%) for predicting disease progression. The AUC for PRECISE (84.4%) was non-significantly higher than AUCs of 81.5%, 78.0%, and 80.9% for PN, LASSO regression, and RF, respectively (p = 0.64, 0.43, and 0.57, respectively). No significant differences were observed between AUCs of the three delta-radiomics models (p-value range 0.34-0.77).

conclusionsPRECISE and delta-radiomics models achieved comparably good performance for predicting PCa progression in AS patients. KEY POINTS: • The observed high specificity and PPV of PRECISE are complemented by the high sensitivity and NPV of delta-radiomics, suggesting a possible synergy between the two image assessment approaches. • The comparable performance of delta-radiomics to PRECISE scores applied by expert readers highlights the prospective use of the former as an objective and standardisable quantitative tool for MRI-guided AS follow-up. • The marginally superior performance of parenclitic networks compared to conventional machine learning algorithms warrants its further use in radiomics research.

Indexed as

Prostatic NeoplasmsWatchful WaitingHumansMagnetic Resonance ImagingMaleProspective StudiesRetrospective StudiesActive surveillanceMachine learningMagnetic resonance imagingPRECISEProstate cancer

Identifiers

PMID34255161
PMCPMC8660717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.